title: Senescent retinal pigment epithelial cells are more sensitive to vascular endothelial growth factor: implications for "wet" age-related macular degeneration.
abstract: OBJECTIVE
  Senescence of the retinal pigment epithelial (RPE) cell layer has been implicated in the occurrence of age-related macular degeneration (AMD). The present study examines whether the ability of vascular endothelial growth factor (VEGF) to decrease the barrier function of RPE cells is enhanced in senescent RPE cells, which could contribute to the pathology of "wet" AMD.
  
  
  METHODS
  Low or high population doubling level (PDL) range ARPE-19 human RPE cells were cultured in 6-well plates on membrane-containing inserts. After 2 weeks, the cells were treated with either VEGF or its vehicle and their transepithelial electrical resistance (TEER) was measured. One week later, the cells were stained for senescence-associated β-galactosidase (SABG) activity.
  
  
  RESULTS
  VEGF was significantly more effective in reducing the TEER of the high PDL ARPE-19 cell layers than the low PDL layers (25% decrease vs. 6% decrease; t-test, P=0.0013). The low PDL cell layers had a modest uniform level of SABG staining. In contrast, the high PDL layers displayed darker and more mottled SABG staining indicative of the presence of senescent cells.
  
  
  CONCLUSIONS
  The present results show that the ability of VEGF to reduce the barrier function of RPE cell layers is greater in high PDL layers, which display signs of senescence, than in low PDL layers. Senescence-induced changes in the responsiveness of RPE cell layers to VEGF could contribute to the pathology of AMD. Agents that strengthen the barrier properties of RPE cells or reduce their responsiveness to VEGF could be effective in treating "wet" AMD.
authors.affiliation: Arizona College of Optometry, Midwestern University , Glendale, Arizona.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Kozlowski
mesh_terms: D002478:Cells, Cultured; D006801:Humans; D011994:Recombinant Proteins / Q000494:pharmacology; D055213:Retinal Pigment Epithelium / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D012168:Retinal Pigments / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology*; D057135:Wet Macular Degeneration / Q000378:metabolism / Q000473:pathology*; D001616:beta-Galactosidase / Q000378:metabolism
chemical_list: D011994:Recombinant Proteins; D012168:Retinal Pigments; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C061901:GLB1 protein, human; D001616:beta-Galactosidase